Day1 Feb 16th (Fri)
12:30-12:40 | Opening Remarks |
12:40-13:30 | Plenary Lecture 1 The Werner Syndrome: Past, Present & Future Session 1 Clinical Features and Genetics of Werner Syndrome |
13:30-14:00 | Lessons from Werner syndrome: A biased view from a rheumatologist Makoto Goto (Nerima Hikarigaoka Hospital, Tokyo, Japan) |
14:00-14:30 | Genomic clues to Werner syndrome disease pathogenesis and cancer risk Raymond J. Monnat (University of Washington, Seattle, USA) |
14:30-15:00 | International Registry of Werner Syndrome: Search for progeroid syndrome mutations and mechanisms Session 2 Bloom Syndrome and Stem Cell Aging in Skin |
15:10-15:40 | NSMCE2 is required for the generation of sister chromatid exchanges at collapsed replication forks Nathan A. Ellis (University of Arizona, Tucson, USA) |
15:40-16:10 | Altered Nucleolar Trafficking of the Blm Helicase in the Mouse Reduces Size, Increases Tumor Susceptibility and Genome Instability, and Facilitates Aging Joanna L. Groden (The Ohio State University, Columbus, USA) |
16:10-16:40 | Stem cells orchestrate hair follicle aging program Patients and Families Session |
16:40-17:00 | From Werner syndrome patient group |
17:00-17:15 | From Cockayne syndrome patient group |
17:15-17:35 | From Rothmund-Thomson syndrome patient group |
17:40-19:10 | Poster Session Welcome Reception at Hotel Okura |
Day2 Feb 17th (Sat)
08:30-09:20 | Plenary Lecture 2 Session 3 Travel Award Presentations and Mini Presentations of Poster Presenters |
09:20-11:20 | Travel Awardees and All the Poster Presenters |
11:30-12:20 | Luncheon Seminar (Sponsored by Novo nordisk Pharma Limited)
|
12:30-13:00 | Update on Clinical Studies of Rothmund-Thomson Syndrome and RECQL4 Disorders |
13:00-13:30 | Role of RECQL4 in genome maintenance |
13:30-14:00 |
Mitol dependent ubiquitylation of RECQL4 prevents its function as an accessory factor for mitochondrial DNA replication |
14:00-14:30 |
Roles of mitochondrial ubiquitin ligase MITOL in mitochondrial dynamics and aging-related diseases |
14:30-15:20 |
Plenary Lecture 3 Chair: Yasuhiro Furuichi (GeneCare Research Institute, Kamakura, Japan)Genome-Wide promotome and enhancerome analysis based on CAGE technology and its application to the identification of cancer biomarkers
Session 5 Aging related Diseases and Hutchinson Gilford Progeria Syndrome (Co-sponsored by Daiichi Sankyo Company, Limited) |
15:40-16:10 |
Mitotic death of cancer cells by gene silencing of RECQ helicases: a preferential sensitivity of ovarian cancer cells to RECQL1-siRNA Yasuhiro Furuichi (GeneCare Research Institute, Kamakura, Japan) |
16:10-16:40 |
Role of Akt in skeletal muscle in anti-aging |
16:40-17:10 |
Immunometabolic regulation of cardiac homeostasis and heart failure in aging |
17:10-17:40 |
The clinical characteristics of Asian patients with classical-type Hutchinson-Gilford progeria syndrome |
17:40-18:30 |
Special Lecture: Photo Session Dinner at Takaraya Takaraya located in Kisarazu, Chiba was established in 1897. |
---------------------------------- Room B ------------------------------------- |
|
Patients and Families Meeting (in Japanese) |
|
09:20-11:20 |
From Patient group of Werner, Cockayne, Rothmund-Thomson syndromes,
|
13:00-13:20 |
Diabetes mellitus and metabolic syndrome |
13:20-13:40 |
Skin ulcer and its prevention |
13:40- |
Good shoes for your health Meister Karsten Rieche (Nature’s Walk, Chiba, Japan) |
Day3 Feb 18th (Sun)
08:00-08:50 | Morning Seminar (Sponsored by MSD K.K.) |
09:00-09:50 | Plenary Lecture 4
|
09:50-10:20 | Coordinated DNA damage recognition by xeroderma pigmentosum gene products |
10:20-10:50 | The present status of Xeroderma pigmentosum in Japan-evaluation of symptoms by severity scale score Chikako Nishigori (Kobe University, Kobe, Japan) |
10:50-11:20 | Very mild Japanese Cockayne syndrome (type-IV) cases with a N-terminal truncation mutation in the ERCC6 / CSB gene
|
11:30-12:00 | Using stem cell and gene editing techniques to study and treat aging-associated disorders Guanghui Liu (Institute of Biophysics, Chinese Academy of Science, Beijing, China) |
12:00-12:30 | In vitro modeling of bilateral progressive hearing loss with human iPSC technology: |
12:30-13:00 | Patient-specific iPS cells for neural disease modeling and drug screening |
13:00-13:10 | Closing Remarks |